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Copyright © 2008 JCBN Summary To explore the metabolic effects of Bcl-2 in tumor cells, a stable clone of HuH-7/
bcl-2 and its control HuH-7/neo were established. Mitochondrial localization of ectopic Bcl-2
was demonstrated both by western blotting and immunofluorescence. HuH-7/bcl-2 cells
consumed glucose at a higher rate, exhausted the available cellular ATP and died on day 9,
while HuH-7/neo cells were still alive for 10 days under the same condition where cells were
cultured without replenishment of the medium. The expression of the hexokinase II gene was
up-regulated in HuH-7/bcl-2 at its protein level. Taken together, we suggest that the forced
expression of Bcl-2 in human hepatoma may cause the cells to become more glucose-dependent
for survival.
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Introduction
Otto Warburg originally proposed a hypothesis for the
energy metabolism of tumor cells that the driving force of
the enhanced glycolysis in hepatoma cells was the energy
deficiency caused by an irreversible damage of the mito-
chondrial function [1]. There appears to be a diminished
oxidative phosphorylation in most tumor cell types, including
hepatoma, from the observations that numerous cancer cells
display mitochondrial DNA deletions, reduced mitochon-
drial content, and impaired oxidative capacity [2]. Following
Warburg, a number of these explanations have been
advocated for experimental tumor cells; however, a common
molecular mechanism of a deficit in oxidative metabolism
has proven still elusive [3].
It is well established that activated oncogenes play pivotal
roles in the tumorigenesis of most tumor types. In particular,
the up-regulation of the oncogenes c-myc, ras, or bcl-2, is a
prevalent feature in various human cancers [4]. Among these
3 genes, the metabolic roles of c-myc have so far been most
successfully investigated, and the c-Myc has been demon-
strated to transactivate the lactate dehydrogenase A (LDH-
A) gene [5], whose product participates in anaerobic
glycolysis, suggesting that the high glycolytic rate in tumor
cells could be explained by the activation of the c-myc gene.
However, the Warburg’s theory of irreversible damage to
mitochondrial function is still difficult to account for by the
c-myc gene alone. The other 2 oncogenes have not been
shown to induce mitochondrial malfunction in respiration.
The mitochondrion has been recognized mainly as an
organelle with the functions of a cellular power plant, which
produces energy for cell to survive [6]. However, a recent
review has extensively described an additional role that
mitochondria play role in cell fate [7]. Apoptotic cell death
is a highly controlled process under the control of certain
gene products. Bcl-2 is well known to prevent apoptosis
by blocking the cyotosolic release of cytochrome c from
mitochondria [7].
We have focused our attention to the bcl-2 oncogene,
which is up-regulated in more than 50% of human tumor
types and the product of which is localized mainly to theK. Okamoto et al.
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mitochondrial outer membrane [7]. In the present study we
established a stable cell clone from human hepatoma-
derived HuH-7 cells, HuH-7/bcl-2, which exhibited consti-
tutive expression of the bcl-2 gene, as well a negative con-
trol clone, HuH-7/neo. The mitochondrial localization of
Bcl-2 forcibly expressed was confirmed both by subcellular
fractionation followed by western blotting, and immuno-
fluorescence with confocal laser scanning microscopy. We
found that HuH-7/bcl-2 cells consumed glucose more rapidly
than HuH-7/neo cells in a high glucose medium, suggesting
that the forced expression of the bcl-2 gene in human
hepatoma may make the cells more glucose-dependent.
Materials and Methods
Cells
Human hepatoma-derived HuH-7 cells were obtained
from RIKEN BioResource Center, Tsukuba, Japan and were
grown in the presence of 5% CO2 with Dulbecco’s modified
Eagle’s (DME) medium containing high glucose (25 mM,
Sigma-Aldrich, St. Louis, MI) with 5% fetal bovine serum
(FBS, Hyclone, Logan, UT). DME medium containing low
glucose (5.5 mM, Sigma-Aldrich) was also used.
Plasmids and stable transfection
An Eco RI fragment of pCMV/bcl-2 (a generous gift from
Dr. Y. Akao, Gifu International Institute of Bioscience), was
subcloned into the Eco RI site of pcDNA3.1(+) (Invitrogen,
CA). HuH-7 cells were transfected with the Bgl II-linearized
pcDNA3.1/bcl-2 or the empty vector, pcDNA3.1(+). Trans-
fected clones were selected by resistance to G418 (150 μg/
ml, Invitrogen) in 6-well plates with a cylinder cloning
method.
Cell proliferation assay
One thousand cells were inoculated per well in a 96-well
culture plate. Cells were detected using the Cell Proliferation
Reagent WST-1 for cell proliferation according to the
protocols of the manufacturer (Roche Diagnostics, Tokyo).
Ten μl/well of WST-1 were added, and incubated for 30 min.
Absorbance was measured in a HTS7000 plate reader
(Hewlett Packard, Palo Alto, CA) at 450 nm with a subtrac-
tion of the cell density background at 690 nm. The experi-
ment was performed in triplicate.
Cellular ATP contents
At the indicated time of culture, cellular ATP content
was evaluated using the CellTiter-Glo® Luminescent Cell
Viability Assay (Promega, Madison, WI) according to the
manufacturer’s instructions. The intensity of luminescence
was measured in a Centro XS3 LB 960 (Berthold Tech-
nology GmbH & Co KG, Germany). The experiment was
performed in triplicate.
Real-time RT-PCR
Real time PCR was performed to quantify the cellular
levels of hexokinase type 2 (HK II) mRNA, in comparison
with those of glucokinase (GK) mRNA. The primers for HK
II were: HK II fw: 5'-ATC CCT GAG GAC ATC ATG CGA-
3' and HK II rev: 5'-CTT ATC CAT GAA GTT AGC CAG
GCA-3'. For GK: GK fw 5'-CTC CCA AAG CAT CTA CCT
CT-3' and GK rev: 5'-TCC TTC TGC ATC CGT CTC AT-3'
were used.
Amplification in the LightCycler capillaries (Roche,
Tokyo) was for 40 cycles with initial incubation of 10 min at
95°C for activation of Taq DNA polymerase in LightCycler
FastStart DNA MasterPLUS SYBR Green I (Roche
Diagnostics, Indianapolis, IN). Cycling parameters were
15 s at 95°C, 10 s at 60°C, and 10 s at 72°C. The second
derivative maximum method was used for quantification
with the LightCycler software (Roche Diagnostics). For
quantification of the results, normalization was performed
by dividing each value calculated for GK or HK II mRNAs
in HuH-7/neo cells.
Subcellular fractionation
Subcellular fractionation was conducted prior to western
blotting. Cells were scraped in Dulbecco’s phosphate
buffered saline, Ca2+ free [PBS (–)] and centrifuged at
1,000 × g for 5 min. The pelleted cells were washed with
0.13 M NaCl, 5 mM KCl, and 1 mM MgCl2. The washed
cells were suspended in 0.01 M Tris-HCl buffer (pH 6.7)
containing 0.01 M KCl and 0.1 mM EDTA. After homo-
genization in 0.2 M sucrose, the cell debris were removed
by centrifugation. The supernatants were centrifuged at
8,300 × g for 19 min; and the pellet was resuspended in
0.25 M sucrose in 0.01 M Tris-HCl, pH 6.7, containing
0.1 mM EDTA, which was referred to as “the mitochondrial
fraction”. The remaining supernatants were centrifuged at
16,700 × g for 19 min; and the resultant supernatants were
saved as “the post-mitochondrial fraction” or, tentatively,
“the cytosolic fraction”.
Western blotting
After being washed with PBS (−), the cells were lysed on
ice in RIPA buffer containing completeTM Mini (protease
inhibitor cocktail, Roche Diagnostics). The mitochondrial
fractions (5 μg total protein) or the post-mitochondrial frac-
tions (10 μg) were heated at 95°C for 5 min, and applied to
a 15% polyacrylamide gel containing 1% SDS. The proteins
were semi-dry blotted onto PVDF membrane (Bio-Rad) and
were incubated with polyclonal anti-bcl-2 antibody (ΔC 21,
Santa Cruz, 1:400) or anti-hexokinase II (HK II, 1:1000,
Cell Signaling, Danvers, MA) at 4°C overnight. Anti-rabbit-
IgG antibody labeled with horseradish peroxidase (Santa
Cruz, 1:800) was detected with ECL plus reagent (GE
Healthcare UK, England). The chemiluminescence wasBcl-2 Enhanced Glucose Requirement in Hepatoma
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Fig. 1. The expression of the bcl-2 gene at its transcriptional and translational levels and mitochondrial localization of Bcl-2 protein in
HuH-7/bcl-2 cells. A: RT-PCR of the bcl-2 gene from total RNA in HuH-7/neo (lane 1) or HuH-7/bcl-2 cells (lane 2). B:
Immunoblot of whole cell lysates with anti-bcl-2 antibody in each 3 HuH-7/neo cell clones (lanes 1, 2, 3), and each 4 HuH-7/
bcl-2 cell clones (lanes 4, 5, 6, 7). Lane M shows molecular weight standard proteins containing 20, 28, 35, 45, 56, and 75 kD.
C: Immunoblots with anti-bcl-2 antibody of the mitochondrial fractions (lanes a, b) and the post-mitochondrial fractions (lanes
c, d) from HuH-7/neo (lanes a, c, in duplicate) and HuH-7/bcl-2 cells (lanes b, d in duplicate). Immunoblots with anti-porin
antibody of the post-mitochondrial fractions (lanes 1, 2) and the mitochondrial fractions (lanes 3, 4) from HuH-7/neo (lanes 1, 3)
and HuH-7/bcl-2 (lanes 2, 4), and with anti-LDH-A antibody of the post-mitochondrial fractions (lanes 5, 6) and the mitochon-
drial fractions (lanes 7, 8) from HuH-7/neo (lanes 5, 7) and HuH-7/bcl-2 (lanes 6, 8). D: Immunofluorescence of Bcl-2 was
observed by a laser-scanning microscopy. Red fluorescence indicates mitochondria with MitoTracker Red and green fluores-
cence displays the distribution of Bcl-2 in HuH-7/bcl-2 (a, b, c) or HuH-7/neo cells (d, e, f).K. Okamoto et al.
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recorded with a LAS 1000plus Intelligent Dark Box II
(Fujifilm, Tokyo). Anti-porin (Calbiochem, Merck,
Darmstadt, Germany, 1:1000) and anti-LDH (Chemicon,
CA, 1:2500) were used to detect marker proteins for mito-
chondria and cytosol fractions, respectively.
Immunofluorescence
Cells were incubated for 30 min with 100 nM MitoTracker-
Red CMXRos (Molecular Probe, Eugene, OR) in FBS-free
DME medium. The cells were then fixed with 4% para-
formaldehyde containing 2% sucrose in PBS (−) for 30 min.
After incubated with anti-bcl-2 antibody (1:400) at 4°C,
overnight, the cells were incubated for 2.5 h at room
temperature with anti-rabbit-IgG-Alexa-488 (Molecular
Probe, 1:1000). The cells mounted in ParmaFlour were
observed under a confocal laser-scanning fluorescence
microscope, LSM 510 equipped with Axiovert 200M (Carl
Zeiss, Germany).
Results
Mitochondrial localization of Bcl-2 in HuH-7/bcl-2 cells
To establish the transfected clones, the expression of the
bcl-2 gene was detected by a RT-PCR method. Fig. 1A
clearly shows the ectopic expression of the bcl-2 gene in
HuH-7/bcl-2 cells, while no transcript was detected in HuH-
7/neo cells. Furthermore, Bcl-2 was detected on western blot
with the RIPA lysates of 4 individual clones of HuH-7/bcl-2,
but not in any of the 3 clones of HuH-7/neo (Fig. 1B). There-
after we used clone 11 (lane 6 in Fig. 1B) of HuH-7/bcl-2 for
further experimentation in the present study. Bcl-2 was
mainly found in mitochondria and barely detected in the
post-mitochondrial fraction (Fig. 1C). The mitochondrial
localization of Bcl-2 was also demonstrated by 2-color
immunofluorescence with confocal laser scanning micros-
copy. Fig. 1D illustrates the co-localization of Bcl-2-specific
green fluorescence with red fluorescence of MitoTracker in
HuH-7/bcl-2 cells, but scarce green fluorescence specific for
Bcl-2 was found in HuH-7/neo cells.
Growth kinetics of HuH-7/bcl-2 and HuH-7/neo cells
The effects of constitutive expression of the bcl-2 gene on
growth were examined with the WST-1 assay. There was no
significant difference in the standard curves of WST-1
colorization vs. cell number, as measured by the Trypan blue
method, between either the HuH-7/neo and HuH-7/bcl-2
cells (data not shown). As shown in Fig. 2A, both HuH-7/
neo and HuH-7/bcl-2 cells started to grow similarly in a
logarithmic mode, and there was no difference in the growth
rate of these 2 cell lines. The both cell populations continued
to expand and reached a maximum density on day 7. The
HuH-7/bcl-2 cells suddenly died on day 8, whereas most of
the HuH-7/neo cells were still alive on day 10 (Fig. 2A).
Next we determined the number of viable cells in a 96-
well plate based on quantitation of the cellular ATP present,
which signals the presence of metabolically active cells. As
shown in Fig. 2B, ATP-contents per well reached a plateau
on day 6 with the HuH-7/bcl-2 cells, then they suddenly
declined and almost disappeared on day 9, while the ATP-
contents of HuH-7/neo cells per well maintained their
plateau level until the end of the experiment. When we
plotted time-dependent changes in the ATP levels at a
cellular basis (Fig. 2C), both cells gradually and continu-
Fig. 2. Growth curves of HuH-7/bcl-2 and HuH-7/neo cells
revealed by WST-1 assay and changes in ATP contents
per well. HuH-7/neo (open circle) and HuH-7/bcl-2 cells
(closed circle) were cultured with 25 mM glucose. A:
Numbers of living cells measured with WST-1 were
plotted per well against days in culture. B: ATP
concentrations (moles per well) the CellTiter Glo assay.
Each points represent mean ± SD (n =3 ) .  * :  p<0.01,
***: p<0.005. C: Cellular ATP concentrations (moles per
cell) were plotted from a calculation of the each value in
panel B divided by the corresponding cell number in
panel A.Bcl-2 Enhanced Glucose Requirement in Hepatoma
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ously decreased their ATP contents until day 7. From day 8
to day 10, HuH-7/neo cells restored the cellular ATP
contents almost up to the initial level, whereas HuH-7/bcl-2
cells exhausted all cellular ATP via its apparent transient
increase.
Enhanced glucose consumption by the forced expression of
the bcl-2 gene
Both cell lines took up large amounts of the glucose in the
medium on day 1. And the concentrations of glucose were
the same with both cell lines from day 2 to day 5 (Fig. 3).
Then, on day 6, HuH-7/bcl-2 cells restarted to uptake glucose
and continued to consume it until day 10, whereas HuH-7/
neo cells restarted to uptake glucose on day 7, one day later
than the HuH-7/bcl-2 cells. Concomitantly, lactate was
secreted and accumulated 1 day earlier in the HuH-7/bcl-2
cells than the HuH-7/neo cells (Fig. 3). The day when the
disappearance curve of glucose and production curve of
lactate in the medium crossed over was day 7 for HuH-7/bcl-
2, and day 8 for HuH-7/neo cells, respectively.
The glucose consumption and lactate production rates
were calculated as shown in Table 1. HuH-7/bcl-2 cells
utilized 65% of the consumed glucose only for the
glycolysis pathway, whereas a nearly equal amount (2732.1
or 2800.2 μg/ml) of lactate was produced in both cell lines.
This indicates the over-expression of the bcl-2 gene in
hepatoma cells induced extra energy metabolism of glucose
in response to mitochondrial respiration in addition to
keeping glycolysis to lactate at a high constant rate.
Enhanced expression of the hexokinase II (HK II) gene by
the forced expression of the bcl-2 gene
Hexokinase is the initial enzyme in the glycolysis
pathway that catalyzes the irreversible reaction of glucose to
glucose-6-phosphate. In order to clarify a mechanism of the
enhanced glucose consumption in HuH-7/bcl-2 cells, the
expression levels of the HK II and GK genes were investi-
gated. As shown in Fig. 4A, the cellular levels of GK mRNA
were not so altered by Bcl-2 in either low or high glucose
medium. The cellular levels of HK II mRNA were also not
so varied by Bcl-2, but were down-regulated by one-third in
high glucose medium. Most interestingly, the cellular levels
of HK II protein were highly up-regulated by Bcl-2 in low
glucose medium, whereas high glucose media down-
Fig. 3. Glucose consumption and lactate production in HuH-7/
neo and HuH-7/bcl-2 cells. HuH-7/neo (open circle) and
HuH-7/bcl-2 (closed circle) was cultured with 25 mM
glucose. Concentrations (μg/ml) of glucose (continuous
line) and lactate (broken line) in medium were plotted
against days in culture. Each points represent mean ± SD
(n =3 ) .
Fig. 4. Up-regulation of HK II expression by Bcl-2 and its
down-regulation by high glucose. A: Real time RT-PCR
analysis of HK II and GK mRNA expression was
performed using total RNA isolated from HuH-7/neo
(open column) and HuH-7/bcl-2 cells (closed column).
Data are normalized for the expression levels or their
ratio of HuH-7/neo in low glucose. B: HK II protein was
analyzed by immunoblot with loading control of GAP-
DH in whole cell lysates of HuH-7/neo (lanes 1, 3) and
HuH-7/bcl-2 cells (lanes 2, 4) cultured with low glucose
(lanes 1, 2) or high glucose (lanes 3, 4).K. Okamoto et al.
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regulated HK II protein levels both in HuH-7/neo and
HuH-7/bcl-2 cells (Fig. 4B).
Discussion
In the present study, it was found the forced expression of
the bcl-2 gene caused an enhanced glucose requirement of
human hepatoma cells, suggesting that this oncogene
apparently brought about by the typical characteristics of
tumor cells.
In addition to preventing apoptotic cell death by inhibiting
the secretion of proapoptotic factors from mitochondria,
Bcl-2 has recently been reported to be involved also in the
energetics of mitochondria [6], an organelle where Bcl-2
mainly resides [8, 9]. To explore a possible metabolic effect
of Bcl-2 on glucose-dependency of tumor cells, we estab-
lished several stable clones of Bcl-2-expressing HuH-7 by
transfection with the bcl-2 gene. HuH-7/bcl-2 cells
expressed Bcl-2 even after the 58th passage, and most of
the protein was localized to mitochondria. Therefore, we
utilized these 2 cell lines, HuH-7/neo and HuH-7/bcl-2, to
investigate the cellular effects of Bcl-2 on glucose metabo-
lism and cell growth.
The most interesting finding in the present study is that in
comparison with HuH-7/neo cells, glucose utilization was
enhanced in HuH-7/bcl-2 cells. Further HuH-7/bcl-2 cells
were selectively killed due to depletion of cellular ATP after
prolonged culture time. This means that when glucose is
sufficiently available, a greater range of malignant cells,
such as HuH-7/bcl-2 cells are able to utilize increased
amounts of glucose for mitochondrial respiration than the
differentiated tumor-type HuH-7/neo cells. However, the
glycolysis rate in HuH-7/bcl-2 cells might be equal to that of
HuH-7/neo cells, because the production rate of lactate was
similar in both cell lines (Table 1). This explanation of the
finding would seem to be inconsistent with two long
standing ideas in the oncology field, i.e. a “Warburg theory”
and the “Crabtree effect” in tumor cells [1]. As is well
known, Warburg proposed putative irreversible damage of
mitochondrial function in most tumors [1]. In contrast, the
present study strongly suggests that the enhanced expression
of Bcl-2 might unexpectedly cause up-regulation of mito-
chondrial utilization of glucose metabolites, or respiration.
Crabtree originally found that a high concentration of
glucose indeed did inhibit mitochondrial respiration [1].
This “Crabtree effect” is a metabolic effect typical of tumor
cells. Therefore, the above-mentioned scenario of constant
glycolysis and up-regulated respiration by high concentra-
tion of glucose may require revision to account for why
HuH-7 hepatoma cells apparently lack the Crabtree effect.
To our knowledge, only a couple of papers have so far
reported an intracellular link between Bcl-2 (or Bcl-xl)
and glucose metabolism [10, 11]. Tome et al. [10] found
that mouse thymic lymphoma cells over-expressing Bcl-2
exhibited increased activity in hexokinase and lactate
production, suggesting a potential increase in glycolysis. In
the present study, we also found the up-regulation of HK II
protein in HuH-7/bcl-2 cells only in low glucose condition,
but failed to find any apparent increase in lactate production
in HuH-7/bcl-2 cells. This may be due to a potential
difference in intrinsic glucose metabolism between lym-
phoma and hepatoma cells. It has been well known that HK
II protein is frequently up-regulated in most tumor cells and
is bound to the outer mitochondrial membrane, whereas
glucokinase is not up-regulated in hepatoma and is the
cytosolic soluble protein [12]. However, the up-regulation of
HK II by bcl-2 over-expression was limited to the low
glucose condition. Therefore, we speculate that the over-
expression of HK II protein may not be a major mechanism
for the enhanced glucose requirement induced by bcl-2 over-
expression.
In contrast, Panickar et al. [ 11] reported that over-
expression of Bcl-xl protected neurons from prolonged
hypoglycemic stress. The authors explained that the preven-
tive effect of the over-expressed Bcl-xl was not on glucose
metabolism, but rather on mitochondrial apoptosis, which
was induced by hypoglycemic stress. However, an alterna-
tive explanation for the prolonged survival of Bcl-xl-over-
Table 1. Glucose consumption and lactate production in HuH-7/neo and HuH-7/bcl-2
cells during 10-day culture.
HuH-7/neo HuH-7/bcl-2
Low Glucose (5.5 mM)
Glucose consumed in total (μg/ml): A 1107.1 1106.0
Lactate produced in total (μg/ml): B 905.6 882.0
B/A × 100 (%) 81.8 79.7
High Glucose (25 mM)
Glucose consumed in total (μg/ml): A 3741.7 4326.5
Lactate produced in total (μg/ml): B 2732.1 2800.2
B/A × 100 (%) 73.0 64.7Bcl-2 Enhanced Glucose Requirement in Hepatoma
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expressing cells is that Bcl-xl promoted the mitochondrial
respiratory function. This is because Bcl-xl and Bcl-2 are
known to be involved in mitochondrial electron transport
system by their interaction with voltage-dependent anion
channels [4, 7]. In fact, in the present study the enhanced
glucose consumption by HuH-7/bcl-2 cells was not due to an
increased metabolic flow to lactate in glycolysis, but was
due to an incremental change in metabolic flow from
glucose to other pathways (Table 1).
Very recently, an interesting and important paper
appeared on the engagement of Bcl-2 with mitochondrial
respiration. Chen et al. [ 13] reported a higher level of
mitochondrial respiration in tumor cells over-expressing
Bcl-2. In this case, the impact of Bcl-2 on mitochondrial
respiration is apparently opposite to the Warburg theory, but
is supporting of the present findings on the enhanced
glucose consumption for the extra-glycolysis in Bcl-2-
expressing HuH-7 cells.
Most oncology scientists would agree that tumor cells are
apparently devoid of the Pasteur effect, which says that an
increase in oxygen pressure brings on a down-regulation of
glycolysis [14]. In our experimental conditions, where cells
were always exposed to normoxia or hyperoxia, no down-
regulation of glycolysis was observed in either cell line,
indicating that HuH-7 cells, whether expressing Bcl-2 or
not, indeed lacked the Pasteur effect.
Finally, it is worth noting that the cellular ATP content in
cells grown with the higher glucose was consistently higher
than in cells incubated with the lower glucose in both cell
lines. The cellular ATP content (0.5–7.5 × 10−14 moles/cell)
measured in this study was in the range of cellular ATP
concentrations of various cultured cells, including HuH-7,
found in the literature [15, 16]. A recent review pointed out
that the average contribution of glycolysis in cellular ATP
production in tumor cells was not markedly different from
that of normal cells [17].
In conclusion, the present study found that the forced
expression of the bcl-2 gene in human hepatoma-derived
HuH-7 cells enhanced glucose consumption when the cells
were grown with high glucose medium. A possible mole-
cular mechanism underlying the enhanced glucose require-
ment of the Bcl-2 expressing HuH-7 cells is favored in terms
of the recently reported Bcl-2-enhanced mitochondrial
respiration, because the expression of the bcl-2 gene in
HuH-7 cells had apparently no effect on the rate of
glycolysis.
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